The Meghmani LLP facility specializes in the production of Paracetamol/Acetaminophen Powder and is backward-integrated for Hydrogen, Caustic-Lye, and HCL. It produces PAP for captive consumption and holds CEP certification (CEP 2015-377), as well as approvals from MCC, WHO-GMP, WCC, ISO-14001, and OHSAS-18001. The facility has filed for USDMF (DMF No:02798) and can provide the open part of USDMF & EDMF for Dossier/ANDA filing. Audits from EuGMP, USFDA, KFDA, and COFEPRIS are expected in 2018, with exports to Asia, Middle-East, Latin-America, Central-America, and Africa markets already underway. In addition, the facility has a significant customer base in India and other major regions.
Products & Services
Acetaminophen Usp
Paracetamol
Paracetamol Acetaminophen DC 77
Paracetamol Acetaminophen DC 83.3%
Sites
MEGHMANI LLP (UNIT-III)
Audited
Country
IndiaAddress
GIDC Dahej II Rd, Gujarat 392130, India
Meghmani
Country
IndiaCity
Dahej
Meghmani Unichem
Country
IndiaCity
Dahej
Country
IndiaAddress
402 116. Maharashtra India. India
Country
IndiaCity
Dhatav
Address
402116. Raigad. India